Sarepta Therapeutics
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Key Statistics
Stock Snapshot
Sarepta Therapeutics(SRPT) stock is priced at $16.75, giving the company a market capitalization of 1.75B. It carries a P/E multiple of -2.07.
On 2026-02-27, Sarepta Therapeutics(SRPT) stock traded between a low of $16.46 and a high of $17.38. Shares are currently priced at $16.75, which is +1.7% above the low and -3.7% below the high.
Sarepta Therapeutics(SRPT) shares are trading with a volume of 1.98M, against a daily average of 2.17M.
During the past year, Sarepta Therapeutics(SRPT) stock moved between $10.42 at its lowest and $109.50 at its peak.
During the past year, Sarepta Therapeutics(SRPT) stock moved between $10.42 at its lowest and $109.50 at its peak.
SRPT News
Citi keeps a Sell rating on Sarepta (SRPT) with an $8 price target following the Q4 report. The sees 2026 as a “reset” year for Elevidys, the analyst tells inve...
Needham analyst Gil Blum has reiterated their bearish stance on SRPT stock, giving a Sell rating yesterday. Claim 50% Off TipRanks Premium Unlock hedge fund-lev...
Earnings Snapshot On Wednesday, Sarepta Therapeutics reported an adjusted loss of $3.58 per share, missing the Wall Street estimate loss of $1.31. Sales reached...
Analyst ratings
58%
of 24 ratingsMore SRPT News
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Sarepta Therapeutics ( (SRPT) ) has issued an announcement. On February 25, 2026, Sarepta Therapeutics said Chief Executive Officer Douglas Ingram notified the...
Sarepta (SRPT) announced the commercial launch of Elevidys in Japan by Chugai Pharmaceutical following its reimbursement listing on Japan’s National Health Insu...
In recent days, a US federal appeals court reversed an earlier ruling that had favored Sarepta Therapeutics in its patent dispute with Regenxbio over AAV gene d...
Advertisement Why Sarepta Therapeutics (SRPT) is on investors’ radar Sarepta Therapeutics (SRPT) has drawn attention after a turbulent stretch for shareholder...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.